spacer
home > subscribe to ICT
ICT SUBSCRIPTION FORM

International Clinical Trials is available free on a controlled basis to strategic decision makers within pharmaceutical companies and their contract partners.

Title:
First Name:
Last Name:
Company Name:
Address 1:
Address 2:
Town / City: ZIP / Post Code:
Country: Other:
Tel.: E-mail:

Please answer the following questions:

1. What is your Primary Field of Work/Business/Industry?



Other:

2. What is your Job Title?



Other:
Additional Information:
Please repeat the security code (not case sensitive)*
   
spacer
News and Press Releases

MedPharm announce expansion of partnership with Palvella Therapeutics in developing a new treatment for the debilitating rare disease, pachyonychia congenita

MedPharm Ltd have announced the expansion of their partnership with Palvella Therapeutics, Inc., a Philadelphia-based biopharmaceutical company focused on developing and commercialising therapies for debilitating, rare genetic diseases. To date, MedPharm has employed its world-renowned specialist formulation expertise to support Palvella’s development of a novel, high-strength rapamycin topical formulation for application to the skin (PTX 022) as a disease-modifying treatment for pachyonychia congenita (PC). Most recently, MedPharm has made arrangements to manufacture the clinical (IMP) batches for use in Palvella’s upcoming Phase 2/3 clinical study.
More info >>

 
Industry Events

Multimodal 2019

18-20 June 2019, NEC, Birmingham, UK

Now in its twelfth year, Multimodal is the UK and Ireland’s premier freight transport, logistics and supply chain management event.  Shippers and cargo owners attend to improve their businesses; by finding ways of moving their products more efficiently and by meeting new suppliers. 
More info >>

.
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement